TargetMol中国(陶术生物) Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
-
Email:
marketing@targetmol.cn
Nationality:
China
WebSite:
https://www.targetmol.cn/
Product List:
29243
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
Product List
Keap1-Nrf2-IN-12
2250082-04-1
Anticancer agent 65
2407861-48-5
sEH/AChE-IN-1
2490589-08-5
GLP-1R agonist 1
2711019-49-5
HDAC1/6-IN-1
2630989-02-3
NU5455
1257235-99-6
HCV-IN-40
2087916-66-1
EZH2-IN-9
2700897-24-9
C5aR-IN-2
2761048-06-8
Anticancer agent 55
2408800-91-7
FXR antagonist 1
2295804-68-9
GLP-1 receptor agonist 7
2736447-04-2
Antiviral agent 20
2407570-07-2
Vasopressin V2 receptor antagonist 1
2648650-50-2
A3N19
2249755-49-3
Mibefradil dihydrochloride hydrate
1049728-52-0
Purinostat mesylate
2650188-32-0
Nenocorilant
1496509-78-4
CYP51/HDAC-IN-1
2502095-64-7
AChE/GSK-3β-IN-1
2412364-73-7
Cap-dependent endonuclease-IN-16
2643370-92-5
RORγt agonist 2
2663787-92-4
AChE/BuChE-IN-3
2742707-47-5
Afatinib oxalate
1398312-64-5
HIV-IN-5
2459929-62-3
COX-2-IN-24
2417995-10-7
RIPK1-IN-10
2682889-51-4
PI3K-IN-27
2742654-38-0
ZIKV-IN-2
910582-16-0
FAK-IN-5
2408317-70-2
c-Met-IN-12
2426675-70-7
Mutant p53 modulator-1
2746371-35-5
CYP3A4-IN-2
2562383-94-0
Antitubercular agent-20
2413124-92-0
Antitumor agent-45
2581082-74-6
EGFR-IN-31
2701563-03-1
MMP-9-IN-5
2581824-80-6
PD-1/PD-L1-IN-20
2159138-01-7
Cap-dependent endonuclease-IN-8
2454680-16-9
hCAI/II-IN-5
2428389-67-5
RET-IN-12
2684252-55-7
PI4KIIIbeta-IN-11
2365241-79-6
Spermine Prodrug-1
2576358-68-2
PLK1/BRD4-IN-1
2412707-81-2
Nampt-IN-8
2453183-75-8
c-Fms-IN-12
2145102-33-4
ALK5-IN-9
2489611-06-3
COX-2-IN-28
2413565-18-9
FGFR3-IN-1
2428743-04-6
Antitumor agent-76
2787593-12-6
HIV-1 protease-IN-5
2525173-96-8
SPH5030
2364326-23-6
B-Raf IN 5
2648698-30-8
FGFR-IN-8
2640217-64-5
ERα antagonist 1
2762423-09-4
CYP3A4-IN-3
2562384-19-2
Antitumor agent-56
2411579-53-6
GLP-1R agonist 10
2762515-25-1
Anticancer agent 50
2487457-15-6
RORγt agonist 3
2664106-24-3
Cap-dependent endonuclease-IN-17
2649362-71-8
Lipid-lowering agent-1
2304859-34-3
MMP-9-IN-4
2581824-39-5
Anticancer agent 61
2413148-53-3
Keap1-Nrf2-IN-14
1928782-31-3
EGFR-IN-50
2044508-48-5
KS100
2408477-54-1
AChE-IN-12
2764664-52-8
HER2-IN-7
2387574-01-6
LXRβ agonist-3
2413308-63-9
SAP2-IN-1
2512847-37-7
BuChE-IN-2
2745118-93-6
GLP-1R agonist 8
2736446-82-3
hCA I-IN-2
2417232-12-1
ACC1/2-IN-1
2350219-22-4
Multi-kinase-IN-2
2095628-21-8
MAT2A-IN-1
2667053-18-9
hCAXII-IN-3
2417232-24-5
EZH2-IN-11
2387402-80-2
BLK-IN-1
1431727-00-2
HIV-1 protease-IN-2
2248124-46-9
α-Glycosidase-IN-1
2428389-66-4
Antitubercular agent-19
2248171-05-1
WNY1613
2650546-39-5
CYP3A4-IN-1
2771297-34-6
Cap-dependent endonuclease-IN-14
2740486-73-9
SARS-CoV-2-IN-19
2244991-17-9
AChE-IN-20
2428389-65-3
A3AR antagonist 1
2413257-74-4
BCR-ABL-IN-4
2669790-59-2
IKKβ-IN-1
2410423-31-1
PAK4-IN-1
2396529-58-9
Estrogen receptor antagonist 3
2730011-50-2
Anticancer agent 67
2691895-66-4
Sitagliptin fenilalanil
1339955-03-1
ATR-IN-5
2601571-19-9
Lp-PLA2-IN-9
2637485-12-0
HBV-IN-19 TFA
2241575-60-8
Anticancer agent 41
1394077-28-1
Cap-dependent endonuclease-IN-5
2416258-53-0
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
Copyright 2007© ChemicalBook. All rights reserved.